# GHK-Cu for beginners GHK-Cu in skin creams and GHK-Cu for injection have different rules and evidence. Promise Peptides prescribes now. U.S. patients only. A licensed U.S. provider reviews each request and decides. Not everyone qualifies. Availability varies by state and treatment. Compounded medicines are not FDA-approved. [Visit Promise Peptides for GHK-Cu](https://mypromise.com/products/ghk-cu?utm_source=neo&utm_medium=affiliate&utm_campaign=starter&utm_content=ghk-cu). Neo may earn money when readers become Promise patients. ## The short version **GHK-Cu** is one of the smallest peptides there is: a chain of just three amino acids holding a single atom of copper. The three-link part, GHK, is found naturally in human blood, saliva and urine. You will meet GHK-Cu in two places. In **skin creams and serums**, it is a cosmetic ingredient, usually listed as "Copper Tripeptide-1". As an **injection**, the same molecule is treated as a drug, and no injectable GHK-Cu drug has been approved by the FDA. Most of the research is in cells, in animals, or in small skin studies. What a cream study found tells you very little about an injection, so this page keeps the two apart. ## What GHK-Cu is The letters stand for its three amino acids, the building blocks of protein: glycine (G), histidine (H) and lysine (K), written GHK. "Cu" is the chemical symbol for copper. The peptide grips one copper atom tightly, and most of the effects researchers describe depend on that copper being attached. The bare peptide without copper does not behave the same way in lab tests. GHK was first found in 1973, in human blood plasma (the liquid part of blood). The same three-link sequence also sits inside collagen, the protein that gives skin and connective tissue their structure. The amount of GHK in the blood drops with age, to less than half between the ages of 20 and 60. ## Two lives: the skin cream and the syringe What a product is sold to do decides which rules apply. **In a skin cream or serum** - What it counts as: A cosmetic ingredient, listed as Copper Tripeptide-1. - FDA approval: Not required before sale for cosmetic ingredients. - Human research: Small skin and hair studies. **As an injection** - What it counts as: A drug. - FDA approval: No injectable GHK-Cu drug is FDA-approved. A compounded preparation is not FDA-approved. - Human research: No reliable human data on how the body handles it. ## Where the research stands **On the skin side**, research goes back decades. A 1988 lab study examined GHK-Cu in skin cells called fibroblasts. It did not test treatment in people. Human studies of creams and serums are small. A 2006 trial studied a copper peptide cream in thirteen people after laser skin resurfacing. It did not test injections. A frequently quoted hair study tested GHK combined with a second ingredient, not GHK-Cu on its own. A 2025 review names the main problem for creams: GHK-Cu gets through the outer layer of skin poorly. Much of today's research is about new ways to carry it in. **On the injection side**, there is very little. There are no reliable human studies on how injected GHK-Cu moves through the body or how long it lasts. The closest data comes from a 1997 rat study, which found the bare peptide was broken down quickly in the bloodstream. Other work on memory, the gut and scarring in organs was done in mice or in cells. Many of the biggest claims, such as GHK switching thousands of genes on and off, come from gene-database analysis and cell studies, not people. Much of the early work came from one researcher and his colleagues, and few unrelated labs have checked it. ## Where GHK-Cu stands with the FDA There is **no FDA-approved GHK-Cu drug** for any use, by any route. - **As a cosmetic**, it can be sold in creams without FDA approval, because U.S. law does not require approval for cosmetic ingredients. That says nothing about injecting it. - **For injection**, the FDA's list of compounding ingredients with safety concerns names "GHK-Cu (for injectable routes of administration)". On the FDA's page current as of April 22, 2026, that entry sits in a table headed "nominated but withdrawn", because the groups that had asked the FDA to consider it took their requests back. The FDA's safety concerns remain printed beside it. A withdrawn request is not an approval. - **For forms that are not injected**, the FDA lists GHK-Cu in "category 1", the group of ingredients it has said it does not plan to act against, under certain conditions, while it decides. That is a hands-off policy, not an approval. Compounding means a pharmacy makes a medicine to order from a prescription, and compounded medicines are not FDA-approved. ## What a prescription route looks like A licensed clinician starts with your health: your history, your other medicines, and whether GHK-Cu makes sense for you at all. The answer can be no. If something is prescribed, a licensed pharmacy decides separately whether it can lawfully prepare it, and a prescription does not guarantee that it will. Because the form changes both the rules and the evidence, it is reasonable to ask which form is being prescribed and which pharmacy would make it. A research-only seller skips all of that: the vial is sold for lab research, labelled not for human use, and no one reviews your health. ## What is not known - **What injected GHK-Cu does in people.** There are no controlled human trials of the injection. - **Copper balance over time.** Taking copper into the body again and again could, in theory, upset the body's balance of copper and zinc. That matters most for people with conditions affecting how the body handles copper, such as Wilson's disease. No human cases of copper overload from GHK-Cu have been published, and it does not apply to ordinary cream use. - **Skin tone.** In a lab study, a related copper peptide raised pigment production in pigment cells, so people prone to dark patches may react differently. - **Skin irritation.** Some people with sensitive skin report redness, itching or dryness from copper peptide creams. ## Talking to a licensed clinician about GHK-Cu Promise Peptides is a U.S. telehealth platform. Promise prescribes peptides now through licensed U.S. providers. A licensed U.S. provider reviews every request and your health history, then decides whether to prescribe. Not everyone qualifies, and the answer can be no. Prescribed medicines are prepared by licensed U.S. compounding pharmacies. Each pharmacy separately decides whether it can lawfully prepare a prescription; a prescription does not guarantee it will be filled. Compounded medicines are not FDA-approved. Injectable GHK-Cu appears in the FDA’s "nominated but withdrawn" table. Its safety concerns remain; withdrawal is not clearance, approval or placement in Category 1. Cosmetic use has separate rules. [How Neo is paid for](https://neopeptides.com/about/#how-neo-is-paid-for) sets out the rest. U.S. patients only. Availability varies by state and by treatment. Promise is LegitScript-certified. That certification is not FDA approval. [Visit Promise Peptides for GHK-Cu](https://mypromise.com/products/ghk-cu?utm_source=neo&utm_medium=affiliate&utm_campaign=starter&utm_content=ghk-cu) Neo may earn money when readers become Promise patients. ## Sources 1. [Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ (FEBS Letters, 1988)](https://pubmed.ncbi.nlm.nih.gov/3169264/). PubMed. 2. [The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures (Life Sciences, 2000)](https://pubmed.ncbi.nlm.nih.gov/11045606/). PubMed. 3. [The human tri-peptide GHK and tissue remodeling (J Biomater Sci Polym Ed, 2008)](https://pubmed.ncbi.nlm.nih.gov/18644225/). PubMed. 4. [GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (BioMed Res Int, 2015)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/). PubMed Central. 5. [Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin (Arch Facial Plast Surg, 2006)](https://pubmed.ncbi.nlm.nih.gov/16847171/). PubMed. 6. [Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth (Ann Dermatol, 2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/). PubMed Central. 7. [Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective (BioImpacts, 2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/). PubMed Central. 8. [Simultaneous determination of glycyl-L-histidyl-L-lysine and its metabolite, L-histidyl-L-lysine, in rat plasma (J Chromatogr B, 1997)](https://pubmed.ncbi.nlm.nih.gov/9187381/). PubMed. 9. [Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines (Biochem Biophys Res Commun, 2025)](https://pubmed.ncbi.nlm.nih.gov/39632290/). PubMed. 10. [FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated](https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated). U.S. Food and Drug Administration. 11. [Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks). U.S. Food and Drug Administration. 12. [Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (category lists)](https://www.fda.gov/media/94155/download?attachment). U.S. Food and Drug Administration. 13. [Compounding and the FDA: Questions and Answers](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers). U.S. Food and Drug Administration. --- A plain-English guide. Not a clinic, not a pharmacy, not a seller. Neo points readers who want care to Promise Peptides. A licensed U.S. provider reviews each request and decides. Not everyone qualifies. U.S. patients only; availability varies by state and treatment. Compounded medicines are not FDA-approved. Neo may earn money when readers become Promise patients. Neo is not affiliated with any company that has used the name Neo Peptides or NeoPeptides.